Vitamin E

Studies of vitamin E in people

11 studies gave vitamin E to people and measured what changed

What changedDesignPeopleSource

no change: Has no effect on japanese knee osteoarthritis measure score

no change: Has no effect on physical function

down: Decreases inflammatory markers

Randomized trial24 weeks80 peopleWomen71.9 ± 5.6 yearsOlder adults; Postmenopausal women; Postmenopausal women with symptomatic knee osteoarthritisMedicine, Oct 16, 2026

down: Decreases LDL-C

Randomized trial90 peopleGeneral population; in healthy volunteersNutrition, metabolism, and cardiovascular diseases : NMCD, Feb 25, 2025

down: Decreases hot flashesnearly one-third of the base amount, P = 0.002

down: Decreases triglycerideP < 0.001

down: Decreases aspartate aminotransferaseP = 0.007

Randomized trialeight weeks84 peopleWomenPostmenopausal womenHealth care for women international, Sep 2, 2022

down: Decreases CTX-0.003 ± 0.09 versus 0.121 ± 0.15 with placebo

Randomized trial12 weeks52 peopleWomenPostmenopausal women; Postmenopausal osteopenic womenNutrients, Nov 25, 2021

down: Decreases hot flashesadjusted mean difference -8.7, 95% CI -0.6 to -15.0, P = 0.029

no change: Has no effect on anxietyP > 0.05

Randomized trial8 weeks93 peopleWomen51.7 yearsPostmenopausal women; postmenopausal hot flashesComplementary therapies in medicine, Nov 26, 2019

no change: Has no effect on fasting blood sugar

Randomized trial8 weeks86 peopleWomenPCOSThe Journal of clinical endocrinology and metabolism, Feb 1, 2019

no change: Has no effect on dementiaHR 0.88 (95% CI 0.64-1.20)

Randomized trialtrial from May 2002; cohort study September 2009 to May 20157,338 peopleMen60 years and olderOlder adults; Cox model adjusted for demographics and baseline comorbiditiesJAMA neurology, Mar 21, 2017

no change: Has no effect on cognitive function

no change: Has no effect on dementia11%/year

no change: Has no effect on mortalityp = 0.086

Randomized trial3 years337 peopleolder than 50 yearsOlder adults; Down syndromeNeurology, May 4, 2016

no change: Has no effect on alanine aminotransferase26% vs 17%

down: Decreases metabolic dysfunction-associated steatohepatitis58% vs 28%

down: Decreases NAFLD Activity Scorechange in mean score, −1.8 vs −0.7

Randomized trial96 weeks121 people81% malemean, 13.1 yearsChildren aged 8 to 17 years with NAFLD and persistently elevated levels of alanine aminotransferaseJAMA, Apr 27, 2011

up: Increases delayed-type hypersensitivity skin response65% increase versus 17% with placebo

up: Increases hepatitis B antibody titer6-fold increase versus 3-fold with placebo

up: Increases tetanus antibody titer

Randomized trial4 months88 peopleat least 65 yearsOlder adults; healthy elderly subjectsJAMA, May 7, 1997

no change: Has no effect on urinary 8-oxodG excretion rate

Randomized trial2 months20 peopleMen35–65 yearsMidlife adults; smokersThe American journal of clinical nutrition, Feb 1, 1997